Sign in or Register   Sign in or Register
  |  

VLDLR

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.
Full Name
Very Low Density Lipoprotein Receptor
Function
Multifunctional cell surface receptor that binds VLDL and transports it into cells by endocytosis and therefore plays an important role in energy metabolism. Binds also to a wide range of other molecules including Reelin/RELN or apolipoprotein E/APOE-containing ligands as well as clusterin/CLU (PubMed:24381170, PubMed:30873003).
In the off-state of the pathway, forms homooligomers or heterooligomers with LRP8 (PubMed:30873003).
Upon binding to ligands, homooligomers are rearranged to higher order receptor clusters that transmit the extracellular RELN signal to intracellular signaling processes by binding to DAB1 (PubMed:30873003).
This interaction results in phosphorylation of DAB1 leading to the ultimate cell responses required for the correct positioning of newly generated neurons. Later, mediates a stop signal for migrating neurons, preventing them from entering the marginal zone (By similarity).
Biological Process
Biological Process cholesterol metabolic process Source:UniProtKB-KW
Biological Process dendrite morphogenesis Source:Ensembl
Biological Process glycoprotein transport Source:BHF-UCL1 Publication
Biological Process lipid transport Source:UniProtKB-KW
Biological Process memory Source:ProtInc1 Publication
Biological Process nervous system development Source:ProtInc1 Publication
Biological Process positive regulation of dendrite development Source:BHF-UCL
Biological Process positive regulation of protein kinase activity Source:Ensembl
Biological Process receptor-mediated endocytosis Source:BHF-UCL1 Publication
Biological Process reelin-mediated signaling pathway Source:BHF-UCL
Biological Process signal transduction Source:ProtInc1 Publication
Biological Process ventral spinal cord development Source:Ensembl
Biological Process very-low-density lipoprotein particle clearance Source:BHF-UCL1 Publication
Cellular Location
Cell membrane
Membrane, clathrin-coated pit
Involvement in disease
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 (CAMRQ1):
An autosomal recessive, congenital, non-progressive cerebellar ataxia associated with disturbed equilibrium, delayed ambulation, intellectual disability, cerebellar hypoplasia and mild cerebral gyral simplification. Additional features include short stature, strabismus, pes planus and, rarely, seizures.
Topology
Extracellular: 28-797
Helical: 798-819
Cytoplasmic: 820-873
PTM
Ubiquitinated at Lys-839 by MYLIP leading to degradation.
Glycosylated.

Anti-VLDLR antibodies

Loading...
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: B047M
Application*: E, WB
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: B046M
Application*: E, B
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: B045M
Application*: E, WB, B
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJL-284
Application*: E, WB
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJL-283
Application*: E
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJL-282
Application*: E, WB
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: VLDLR/1337
Application*: WB, F, P, IF
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse, Rat, Cattle
Clone: 6A6
Application*: WB, IH, IC/IF, P
Target: VLDLR
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse
Clone: 1H10
Application*: E, F, WB
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Go to
Compare